About DTxCC

DTxCC is a boutique consultancy focused solely on Digital Therapeutics commercialization

DTxCC consultants have real-world digital therapeutic commercialization expertise specializing in:

• Market Access

• Reimbursement

• Monetization strategies

​

Our Payer Advisory Council provides actionable insight

• Custom qualitative research

  • One-one-one Telephone / web-meeting interviews

• Advisory board meetings

  • Four hour live face-to-face meetings

  • Cost efficient with AMCP national conferences

  • Standalone option to accommodate client needs and timing

​

DTxCC provides guidance through each stage of business development,

maximizing commercialization opportunities in digital therapeutics.

​​​

LEVERAGE THE INSIGHTS AND EXPERTISE of consultants

with deep digital therapeutics experience.

Our team supports end-to-end business planning by evaluating

and creating customized plans

What We Do

DTxCC has a defined process of analysis and research

to generate optimal commercialization strategies

                 Review, Analyze, Research

Go-to-Market Strategies

• Analyze environment and competitive landscape

• Create business models and value propositions

• Identify target markets and partnership opportunities

• Develop monetization approach and forecast revenue

• Product launch and lifecycle management

​

Monetization Options

• Develop coding and payment strategies / models

• Create payer reimbursement and direct pay strategies

• Assemble payer advisory council for strategic guidance

• Targeted commercial payer field based account management team

​

Meet The Team

Rick Bartels, MBA

Managing Partner

 Read Rick's Bio

Jake Schutz - Sr Advisor

Digital Health Strategist

 Read Jake's Bio

Rick Neafus

Data & Technology Advisor

 Read Rick's Bio

Meet The Consultants

Tom Tack

Senior Consultant

 Read Tom's Bio

Andy Tenaglia

Senior Consultant

 Read Andy's Bio

Tom (T.Y.) Yelle

Senior Consultant

 Read T.Y.'s Bio

Rick Gonvalez

Senior Consultant

 Read Rick's Bio

Digital Therapeutic Reimbursement Advisory Council

Now available for custom research and advice:

The council consist of a select group of highly specialized Subject Matter Experts possessing Digital Therapeutics reimbursement and experienced in the evaluation of digital therapeutics for reimbursement.

Our Payer Advisory Council provides actionable insight

• Custom qualitative research

  • One-one-one Telephone / web-meeting interviews

• Advisory board meetings

  • Four hour live face-to-face meetings

  • Cost efficient with AMCP national conferences

  • Standalone option to accommodate client needs and timing

​

Council members include:

-  Managed care Medical and Pharmacy Directors

     - National and regional MCOs

     - Pharmacy Benefits Management companies

 - Integrated delivery networks

-  Employer benefit group management

-  Population Health experts

​

Leverage the Digital Therapeutic Reimbursement Advisory Council

To gain valuable DTx reimbursement insight

DTxCC Strategic Partner:

Clinical SCORE operates at the commercial-clinical intersection, operating
simultaneously as investigator site, CRO and business research firm.

Clinical SCORE capabilities for digital therapeutics clinical trials

• Has a 15-year history of conducting clinical studies

• Acts as the sole investigator (PI) in the clinical studies

• Eliminates the need for additional investigator sites through digital consenting and data

       collection from study participants

• Has experienced investigators with proven history of success

• Writes protocols, manages paperwork and IRB submission

Contact Us

Homestead Drive, West Chester, PA 19382 

  |  Tel: 610-533-2118

© 2021 by Digital Therapeutics Commercialization Consultants, LLC.